MCID: RTC005
MIFTS: 48

Reticulosarcoma

Categories: Cancer diseases, Immune diseases, Rare diseases

Aliases & Classifications for Reticulosarcoma

MalaCards integrated aliases for Reticulosarcoma:

Name: Reticulosarcoma 12 15 73
Lymphoma, Large-Cell 76 53
Diffuse Large B-Cell Lymphoma 73
Lymphoma, Non-Hodgkin 44
Histiocytic Lymphoma 12
Large-Cell Lymphomas 12
Large Cell Lymphoma 53
Histiocytic Sarcoma 73
Lymphoma Large Cell 55

Classifications:



External Ids:

Disease Ontology 12 DOID:8538
ICD9CM 35 200.0 200.7
MeSH 44 D008228
NCIt 50 C27824
SNOMED-CT 68 40152000

Summaries for Reticulosarcoma

MalaCards based summary : Reticulosarcoma, also known as lymphoma, large-cell, is related to alk-positive anaplastic large cell lymphoma and anaplastic large cell lymphoma. An important gene associated with Reticulosarcoma is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are Allograft rejection and NF-kappaB Signaling. The drugs Adcetris and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and bone, and related phenotypes are endocrine/exocrine gland and hematopoietic system

Wikipedia : 76 Anaplastic large-cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma involving aberrant T cells or... more...

Related Diseases for Reticulosarcoma

Diseases related to Reticulosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 293)
# Related Disease Score Top Affiliating Genes
1 alk-positive anaplastic large cell lymphoma 34.0 ALK MUC1 NPM1
2 anaplastic large cell lymphoma 33.5 ALK CLU GZMB MUC1 NPM1 PAX5
3 primary cutaneous anaplastic large cell lymphoma 33.2 ALK GZMB MUC1 NPM1 PTPRC TIA1
4 lymphoma, non-hodgkin, familial 33.2 ALK B2M BCL6 CASP3 CCND3 GZMB
5 intravascular large b-cell lymphoma 32.7 B2M BCL6
6 reticulum cell sarcoma 32.0 MUC1 PTPRC TNFRSF8
7 plasmablastic lymphoma 31.9 BCL6 MUC1 PTPRC
8 lymphoma, hodgkin, classic 31.0 ALK BCL6 PAX5 PTPRC
9 lymphomatoid papulosis 30.9 ALK GZMB NPM1 TIA1
10 hodgkin's lymphoma, lymphocytic-histiocytic predominance 30.6 BCL6 PTPRC
11 autoimmune lymphoproliferative syndrome, type v 30.4 ALK BCL6 TIA1 TRB
12 peripheral t-cell lymphoma 30.3 ALK BCL6 GZMB TIA1 TNFRSF8
13 lymphoma 30.2 ALK BCL6 NPM1 PAX5 TNFRSF8
14 mycosis fungoides 30.2 CLU GZMB TIA1 TNFRSF8
15 subcutaneous panniculitis-like t-cell lymphoma 30.2 GZMB TIA1
16 orbit lymphoma 30.1 GZMB TIA1
17 lymphomatoid granulomatosis 30.0 GZMB TIA1
18 primary effusion lymphoma 29.9 BCL6 CASP3
19 angioimmunoblastic t-cell lymphoma 29.8 BCL6 GZMB TIA1
20 adult lymphoma 29.8 ALK TNFRSF8
21 composite lymphoma 29.8 BCL6 GZMB PAX5 TIA1
22 leukemia, acute myeloid 29.8 ANPEP CASP3 NPM1 PTPRC
23 myeloid sarcoma 29.7 ANPEP NPM1 PAX5 PTPRC
24 mantle cell lymphoma 29.6 BCL6 CASP3 CCND3 PAX5 PTPRC
25 myeloma, multiple 29.5 B2M CASP3 CCND3 PTPRC
26 acute promyelocytic leukemia 29.5 ANPEP CASP3 NPM1 PTPRC
27 burkitt lymphoma 29.5 BCL6 CASP3 CCND3 PAX5
28 b-cell expansion with nfkb and t-cell anergy 29.5 B2M GZMB TIA1 TRB
29 ewing sarcoma 29.3 ALK CASP3 CCND3 PTPRC TNFRSF8
30 b-cell lymphomas 29.3 BCL6 CASP3 CCND3 PAX5 TIA1 TNFRSF8
31 leukemia, chronic lymphocytic 29.1 ANPEP B2M BCL6 CASP3 PAX5 PTPRC
32 alk-negative anaplastic large cell lymphoma 12.7
33 primary mediastinal b-cell lymphoma 11.8
34 anaplastic small cell lymphoma 11.7
35 lymphoma, large-cell, immunoblastic 11.6
36 primary mediastinal large b-cell lymphoma 11.5
37 lymphoma, gastric non hodgkins type 11.4
38 langerhans cell histiocytosis 11.2
39 lymphosarcoma 10.4
40 heart lymphoma 10.3 BCL6 PTPRC
41 testicular lymphoma 10.2 BCL6 PTPRC
42 lichen sclerosus et atrophicus 10.2 GZMB TIA1
43 nodular lymphocyte predominant hodgkin lymphoma 10.2 BCL6 PAX5
44 viral esophagitis 10.2 GZMB TIA1
45 sarcoma 10.2
46 lymphocytic gastritis 10.2 GZMB TIA1
47 intraocular lymphoma 10.2 BCL6 PAX5
48 hepatosplenic t-cell lymphoma 10.2 GZMB TIA1
49 t-cell/histiocyte rich large b cell lymphoma 10.2 BCL6 TNFRSF8
50 conventional fibrosarcoma 10.2 PTPRC TNFRSF8

Graphical network of the top 20 diseases related to Reticulosarcoma:



Diseases related to Reticulosarcoma

Symptoms & Phenotypes for Reticulosarcoma

MGI Mouse Phenotypes related to Reticulosarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.86 ALK ANPEP B2M BCL6 CASP3 CCND3
2 hematopoietic system MP:0005397 9.85 ANPEP B2M BCL6 CASP3 CCND3 NPM1
3 immune system MP:0005387 9.7 ANPEP B2M BCL6 CASP3 CCND3 CLU
4 neoplasm MP:0002006 9.1 ALK B2M CCND3 NPM1 PAX5 PTPRC

Drugs & Therapeutics for Reticulosarcoma

FDA approved drugs:

# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Adcetris 18 49 BRENTUXIMAB VEDOTIN Seattle Genetics August 2011

Drugs for Reticulosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 501)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 6055-19-2, 50-18-0 2907
2
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
3
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57-22-7, 2068-78-2 5978
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-02-2 5743
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1177-87-3
7
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
8
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3778-73-2 3690
9
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
10
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
11
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
12
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
14
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 6006 143
15
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
16
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
17
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-05-2, 1959-05-2 126941
18
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
19
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
20
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
21
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
22
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
23
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-75-2 4033
24
Crizotinib Approved Phase 4,Phase 1,Phase 2 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
26
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 31703
27
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2920-86-7
28
Pirarubicin Investigational Phase 4 72496-41-4
29
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 0
30 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
31 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
32 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
34 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
36 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
37 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
40 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 BB 1101 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
44 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
46 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 885)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Recruiting NCT01909934 Phase 4 brentuximab vedotin
5 Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL Recruiting NCT03707847 Phase 4 Crizotinib;Etoposide Capsule
6 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
7 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
8 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
9 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
10 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
11 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
12 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
13 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
14 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
15 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
16 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
17 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
18 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
19 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
20 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
21 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
22 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
23 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
24 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
25 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
26 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) Completed NCT01578499 Phase 3 Brentuximab Vedotin;Methotrexate;Bexarotene
27 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
28 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
29 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
30 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
31 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
32 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
33 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
34 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
35 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
36 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
37 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
38 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
39 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
40 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
41 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
42 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
44 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
45 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
46 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
47 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
48 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
49 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
50 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin

Search NIH Clinical Center for Reticulosarcoma

Cochrane evidence based reviews: lymphoma, non-hodgkin

Genetic Tests for Reticulosarcoma

Anatomical Context for Reticulosarcoma

MalaCards organs/tissues related to Reticulosarcoma:

41
B Cells, T Cells, Bone, Liver, Bone Marrow, Lung, Thyroid

Publications for Reticulosarcoma

Articles related to Reticulosarcoma:

(show top 50) (show all 83)
# Title Authors Year
1
An interesting case report of pancytopenia in a HIV seropositive patient-Primary bone marrow non Hodgkin's lymphoma large cell type. ( 27728570 )
2016
2
Establishment of a Patient-Derived Xenograft of Canine Enteropathy-Associated T-Cell Lymphoma, Large Cell Type. ( 28011041 )
2016
3
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. ( 11426330 )
2001
4
Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma. ( 10589081 )
1999
5
In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin. ( 8943689 )
1996
6
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. ( 2189589 )
1990
7
[A rare case of manifestation of reticulosarcoma by development of multiple cerebral hemorrhages]. ( 1963966 )
1990
8
[Treatment results in localized forms of reticulosarcoma and Ewing's sarcoma in children]. ( 2662605 )
1989
9
B lymphocytic lymphoma (large cell) of possible splenic marginal zone origin presenting with prominent splenomegaly and unusual cordal red pulp distribution. ( 3292036 )
1988
10
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. ( 3315188 )
1987
11
Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. ( 3322541 )
1987
12
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. ( 3100032 )
1987
13
Primary reticulosarcoma of bone (non-Hodgkin's lymphoma). A study of 12 cases. ( 3503874 )
1987
14
Malignant lymphoma, large cell immunoblastic clear cell showing unusual histologic picture. ( 2956826 )
1987
15
Round-cell sarcomas of bone and their differential diagnosis (with particular emphasis on Ewing's sarcoma and reticulosarcoma). A study of 233 tumors with optical and electron microscopic techniques. ( 6763672 )
1982
16
[State of lymph node stroma in lympho- and reticulosarcoma]. ( 6994695 )
1980
17
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization. ( 370939 )
1978
18
Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (hematosarcomas or non-Hodgkin's lymphomas). ( 373918 )
1978
19
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. ( 373920 )
1978
20
Morphology of lymphoreticular tissues in mice with reticulosarcoma. ( 365565 )
1978
21
Modifications of macrophage chemotaxis in rats bearing the transplantable tumour reticulosarcoma 'IRE'. ( 335481 )
1977
22
Combination chemotherapy with adriamycine, VM 26, cyclophosphamide and prednisone in lymphosarcoma and reticulosarcoma stage III and IV. ( 326554 )
1977
23
Malignant lymphoma (reticulosarcoma) in bone. ( 334431 )
1977
24
Adult coeliac disease. A case with ulceration, dermatitis herpetiformis and reticulosarcoma. ( 766153 )
1976
25
Pathogenesis of ascites in a murine transplantable reticulosarcoma type A. ( 137595 )
1976
26
Hairy cell leukemia ('leukemic reticuleondotheliosis'), reticulosarcoma, and monocytic leukemia. Cytochemical and ultrastructural investigations. ( 808067 )
1975
27
Microglioma and/or reticulosarcoma of the nervous system. ( 51573 )
1975
28
Reticulosarcoma occurring during long-term hemodialysis. ( 1092500 )
1975
29
The effect of immunostimulation and chemotherapy on the growth of reticulosarcoma in mice. ( 4618487 )
1974
30
Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status). ( 4573872 )
1973
31
Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis. ( 4583173 )
1973
32
Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity. ( 4128515 )
1973
33
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression. ( 4577331 )
1973
34
Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. ( 4622181 )
1972
35
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma. ( 4925076 )
1971
36
Reticulosarcoma and amyloid development in BALB/c mice inoculated with syngeneic cells from young and old donors. ( 4941118 )
1971
37
Cytogenetic analysis in two cases of lymphoma. Comparison between lymphosarcoma and reticulosarcoma. ( 4910257 )
1970
38
Reticulosarcoma of the stomach. Report of 13 cases with follow-up results. ( 4931920 )
1970
39
Primary cerebral reticulosarcoma. ( 4913659 )
1970
40
Reticulosarcoma of the caecum. ( 5337477 )
1967
41
Electron microscopic study of tonsillar reticulosarcoma. II. Effect of radiation on tumor cells. ( 4886967 )
1967
42
Electron microscopic study of tonsillar reticulosarcoma. I. Features of malignancy in tumor cells. ( 4886966 )
1967
43
Reticulosarcoma of the eye treated with cyclophosphamide. ( 5336275 )
1966
44
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA. ( 14331625 )
1965
45
LYMPHOGRAPHY WITH RADIOACTIVE CONTRAST MEDIUM IN LYMPHOSARCOMA AND RETICULOSARCOMA. ( 14247471 )
1965
46
INTESTINAL RETICULOSARCOMA IN IDIOPATHIC STEATORRHOEA. ( 14273509 )
1964
47
ACQUIRED HYPOGAMMAGLOBULINAEMIA COMPLICATED BY RETICULOSARCOMA. ( 14098564 )
1963
48
Primary reticulosarcoma of the thyroid gland. ( 13742171 )
1961
49
Malignant tumours of the stomach arising from the lympho-reticular system. A report of 10 cases of lymphosarcoma and reticulosarcoma of the stomach. ( 14492653 )
1961
50
Case of Mesenteric Reticulosarcoma Associated with Gluten-sensitive Steatorrhoea. ( 20789212 )
1961

Variations for Reticulosarcoma

Expression for Reticulosarcoma

Search GEO for disease gene expression data for Reticulosarcoma.

Pathways for Reticulosarcoma

GO Terms for Reticulosarcoma

Cellular components related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.17 ALK ANPEP B2M CLU MUC1 PTPRC

Biological processes related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of cell proliferation GO:0042127 9.54 ALK BCL6 CCND3
2 adult behavior GO:0030534 9.4 ALK PAX5
3 positive regulation of T cell mediated cytotoxicity GO:0001916 9.32 B2M PTPRC
4 positive regulation of receptor-mediated endocytosis GO:0048260 9.26 B2M CLU
5 T cell proliferation GO:0042098 9.16 CCND3 PTPRC
6 regulation of B cell receptor signaling pathway GO:0050855 8.96 PAX5 PTPRC
7 positive regulation of NF-kappaB transcription factor activity GO:0051092 8.92 ALK CLU NPM1 TNFRSF8

Sources for Reticulosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....